DETAILS OF THE SUPPLY AGREEMENT Sample Clauses

DETAILS OF THE SUPPLY AGREEMENT. The salient terms of the Supply Agreement are set out below: a) Glomaxes has committed to GHP for the supply up to 30 million latex gloves per month to GHP (“Glomaxes Commitment”); b) supply term is for 2 years from the date of the Supply Agreement (“Tenure”); c) the price for the supply of latex gloves will be based on the price to be agreed between GHP and Glomaxes for each order over the Tenure; d) The Supply Agreement shall come into force on 10 December 2020 and shall continue in force for a period of two (2) years. The Party may terminate the Supply Agreement by serving at least three (3) month’s written notice to the other party on the occurrence of any one or more of the following events: i) the Party becomes insolvent, the Party is voluntarily liquidated or any analogous event occurs to the Party; ii) GHP fails to pay the price for the latex gloves when due and payable pursuant to the terms of the Supply Agreement; iii) Glomaxes fails to conform the expected standard of the latex gloves; iv) there is a breach of the terms and conditions of the Supply Agreement and the defaulting party has failed to remedy the breach within one (1) month upon being notified by the other Party in writing of the breach; v) there is a dispute with regards to the Supply Agreement which is unable to resolve amicably by the Parties within one (1) month from the date the dispute first occurred; or vi) mutual agreement between the Parties to terminate the Supply Agreement.
AutoNDA by SimpleDocs
DETAILS OF THE SUPPLY AGREEMENT. On 25 June 2020, the Company announced that Anzo Group has entered into a supply agreement for the supply of the Products to CSTME (“Initial Supply Agreement”). On 29 June 2020, 1 July 2020 and 2 July 2020, the Company announced that the Board had furnished additional information pertaining to the Initial Supply Agreement to Bursa Malaysia Securities Berhad (“Bursa Securities”), among others, that the Initial Supply Agreement with CSTME (a company which is controlled by Xxxxxx Xxx Yean Heong (“Xxxxxx Xxx”) who is one of the previous major shareholders of Anzo as disclosed in Section 2.1 of this announcement) was deemed as a related party transaction pursuant to Part E, Chapter 10 of the Main Market Listing Requirements of Bursa Securities (“Listing Requirements”) in view of the interests of Xxxxxx Xxx in Anzo and CSTME. Pursuant to Paragraph 10.02(g) of the Listing Requirements, the highest percentage ratio applicable to the Initial Supply Agreement is 908.22% based on the estimated total contract value of the Initial Supply Agreement of approximately RM1.30 billion compared against the audited consolidated net assets (“NA”) of Anzo Group for the financial year ended (“FYE”) 31 July 2019 of RM143.14 million. The Initial Supply Agreement was deemed as a related party transaction with the highest percentage ratio exceeding the threshold ( > 5%) set out in Paragraph 10.08(2) of the Listing Requirements, therefore Anzo is required to obtain its shareholders’ approval for the Initial Supply Agreement in general meeting. On 5 October 2020, Anzo Trading entered into the Supply Agreement with CSTME to replace and supersede the Initial Supply Agreement in order for Anzo Group to nominate Anzo Trading to undertake the supply of the Products to CSTME and to include new terms which have been mutually agreed between Anzo Trading and CSTME (as set out in Appendix I of this announcement). Pursuant to the Supply Agreement, Anzo Trading agreed to supply and CSTME agreed to purchase 60,000 metric tonne (“MT”) of the Products over 40 months from the date when the Supply Agreement becomes unconditional. The Supply Agreement is conditional upon Anzo obtaining the approval of its shareholders at the forthcoming extraordinary general meeting to be convened by Anzo (“EGM”) for the Supply Agreement and the Proposed Diversification within 3 months from the date of the Supply Agreement or such other period as agreed by Anzo Trading and CSTME. As such, Anzo intends to seek its shareh...
DETAILS OF THE SUPPLY AGREEMENT. The salient terms of the Supply Agreement are, as set out below: a) CSTME had committed to Posco International Corporation (“Posco”) for the supply of copper scrap to Posco (“Posco Commitment”). b) CSTME is desirous to purchase the Products from Anzo Group to fulfil the Posco Commitment.

Related to DETAILS OF THE SUPPLY AGREEMENT

  • Supply Agreement Seller and Buyer, or their Affiliates, shall have executed the Supply Agreement.

  • Supply Agreements For a period of three years from the consummation of the IPO, Odetics shall not unilaterally terminate or assign its guarantee obligation with respect to any supply agreement pursuant to which it has guaranteed the performance by ATL of ATL's obligations, unless such suppliers have consented to the termination or assignment of such guarantee.

  • Quality Agreement Concurrently with execution of this Agreement, the Parties will enter into an agreement that details the quality assurance obligations of each Party with respect to the Manufacture and supply of Supplied Products under this Agreement (the “Quality Agreement”). Each Party shall perform its obligations under the Quality Agreement in accordance with the terms and conditions thereof. In the event of a conflict between the terms of the Quality Agreement and the terms of this Agreement, the provisions of the Quality Agreement shall govern.

  • Pharmacovigilance Agreement Subject to the terms of this Agreement, and at a date to be determined by the JDC, Facet and Trubion shall define and finalize the actions the Parties shall employ to protect patients and promote their well-being in a written agreement (hereinafter referred to as the “Pharmacovigilance Agreement”). These responsibilities shall include mutually acceptable guidelines and procedures for the receipt, investigation, recordation, communication, and exchange (as between the Parties) of adverse event reports, pregnancy reports, and any other information concerning the safety of any Collaboration Product. Such guidelines and procedures shall be in accordance with, and enable the Parties to fulfill, local and national regulatory reporting obligations to Governmental Authorities. Furthermore, such agreed procedures shall be consistent with relevant ICH guidelines, except where said guidelines may conflict with existing local regulatory safety reporting requirements, in which case local reporting requirements shall prevail. The Pharmacovigilance Agreement will provide for a worldwide safety database to be maintained by the Party appointed by the JDC. Each Party hereby agrees to comply with its respective obligations under such Pharmacovigilance Agreement (as the Parties may agree to modify it from time to time) and to cause its Affiliates and permitted sublicensees to comply with such obligations.

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • Manufacturing and Supply (a) Depomed shall supply Product for use in conducting Depomed’s development activities for Product in the Field and in the Territory as set forth in Exhibit D. (b) During the four-year period beginning on the Effective Date (the “Supply Period”), Depomed shall supply and package (or have supplied and packaged) Product pursuant to this Section 4.8. Depomed will use commercially reasonable efforts to enter into a long-term Product supply agreement with [***] days after the Effective Date (the “Depomed Supply Agreement”) that will be freely assignable to Solvay or its Affiliates, successors or assigns at any time. In addition, Depomed and Solvay will negotiate and enter into a Product supply agreement with business terms substantially similar to the Depomed Supply Agreement concurrently with the execution and delivery by Depomed and [***] of the Depomed Supply Agreement (the “Solvay Supply Agreement”, and, together with the Depomed Supply Agreement, the “Supply Agreements”). The Supply Agreements will, together, contain the following provisions (among others mutually agreeable to the Parties): (i) Under the Solvay Supply Agreement, Depomed will agree to supply Solvay with its requirements of finished, packaged Product during the Supply Period; (ii) All manufacturing and records will be performed and maintained in accordance with specifications, cGMP and Applicable Law; (iii) Depomed will provide reasonable assistance to Solvay in the event Solvay wishes to qualify a backup Product manufacturer; (iv) Depomed shall [***]; (v) Solvay will pay Depomed the following amounts in connection with all activities performed by or on behalf of Depomed associated with Product manufacture and supply (other than activities specified on Exhibit D) (A) [***]% of Depomed’s out-of-pocket costs incurred in connection with such manufacture and supply of Product to Solvay, and (B) a labor charge equal to the FTE Charges for all Depomed employees allocated to the manufacture and supply of Product to Solvay, not to exceed FTE Charges for an aggregate of [***] during any given calendar quarter (and Depomed shall provide to Solvay periodic reports detailing the FTE Charges for which Solvay must pay Depomed hereunder);

  • Development Agreement As soon as reasonably practicable following the ISO’s selection of a transmission Generator Deactivation Solution, the ISO shall tender to the Developer that proposed the selected transmission Generator Deactivation Solution a draft Development Agreement, with draft appendices completed by the ISO to the extent practicable, for review and completion by the Developer. The draft Development Agreement shall be in the form of the ISO’s Commission-approved Development Agreement for its reliability planning process, which is in Appendix C in Section 31.7 of Attachment Y of the ISO OATT, as amended by the ISO to reflect the Generator Deactivation Process. The ISO and the Developer shall finalize the Development Agreement and appendices as soon as reasonably practicable after the ISO’s tendering of the draft Development Agreement. For purposes of finalizing the Development Agreement, the ISO and Developer shall develop the description and dates for the milestones necessary to develop and construct the selected project by the required in-service date identified in the Generator Deactivation Assessment, including the milestones for obtaining all necessary authorizations. Any milestone that requires action by a Connecting Transmission Owner or Affected System Operator identified pursuant to Attachment P of the ISO OATT to complete must be included as an Advisory Milestone, as that term is defined in the Development Agreement. If the ISO or the Developer determines that negotiations are at an impasse, the ISO may file the Development Agreement in unexecuted form with the Commission on its own, or following the Developer’s request in writing that the agreement be filed unexecuted. If the Development Agreement is executed by both parties, the ISO shall file the agreement with the Commission for its acceptance within ten (10) Business Days after the execution of the Development Agreement by both parties. If the Developer requests that the Development Agreement be filed unexecuted, the ISO shall file the agreement at the Commission within ten (10) Business Days of receipt of the request from the Developer. The ISO will draft, to the extent practicable, the portions of the Development Agreement and appendices that are in dispute and will provide an explanation to the Commission of any matters as to which the parties disagree. The Developer will provide in a separate filing any comments that it has on the unexecuted agreement, including any alternative positions it may have with respect to the disputed provisions. Upon the ISO’s and the Developer’s execution of the Development Agreement or the ISO’s filing of an unexecuted Development Agreement with the Commission, the ISO and the Developer shall perform their respective obligations in accordance with the terms of the Development Agreement that are not in dispute, subject to modification by the Commission. The Connecting Transmission Owner(s) and Affected System Operator(s) that are identified in Attachment P of the ISO OATT in connection with the selected transmission Generator Deactivation Solution shall act in good faith in timely performing their obligations that are required for the Developer to satisfy its obligations under the Development Agreement.

  • Services Agreement “Services Agreement” shall mean any present or future agreements, either written or oral, between Covered Entity and Business Associate under which Business Associate provides services to Covered Entity which involve the use or disclosure of Protected Health Information. The Services Agreement is amended by and incorporates the terms of this BA Agreement.

  • License Agreement The Trust shall have the non-exclusive right to use the name "Invesco" to designate any current or future series of shares only so long as Invesco Advisers, Inc. serves as investment manager or adviser to the Trust with respect to such series of shares.

  • Master Services Agreement This Agreement is a master agreement governing the relationship between the Parties solely with regard to State Street’s provision of Services to each BTC Recipient under the applicable Service Modules.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!